Rivastigmine Actavis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rivastigmine Actavis, covering 2025-06-13 to 2025-06-13. Get the full timeline:
Most recent: EMA Authorised: Rivastigmine Actavis (rivastigmine hydrogen tartrate) — Actavis Group PTC ehf